Displaying 133 - 144 items out of 159 results
ILCN article
Session to Explore Unmet Patient Needs, Opportunities in Lung Cancer
… the Go2 Foundation’s Brittney Nichols, MPH—will present research on global challenges in lung cancer care during the …
ILCN article
Choose from a Broad Array of Workshop Offerings
… range of specialties and interests, such as early-career research, genomics, communication, radiation, and more. … …
ILCN article
Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates
… Researchers say increased screening of at-risk populations, …
ILCN article
Third Annual Amazing Case Race Returns for WCLC 2025
ILCN article
New Approaches Improve Mesothelioma Outcomes
… be replaced by “mesothelioma” for all uses, pathology researcher says. … New Approaches Improve Mesothelioma Outcomes …
ILCN article
Pragmatic Approach to Trial Design Born from Lung-MAP Substudy
… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …
ILCN article
Dr. Patrick Forde Discusses Excitement Around Neoadjuvant Immunotherapy for Lung Cancer
… Forde, who is director of the Thoracic Oncology Clinical Research Program and associate professor of Oncology at Johns …
ILCN article
In the Wake of Pandemic-Era Care Disruptions, New Challenges Arise
… COVID-19 challenges and encourage attendees to support research on the disease's implications on risk of lung cancer. …
ILCN article
Undruggable No More: KRAS Experts Review What is Known—and Unknown—About This Challenging Alteration
… to target this oncogenic driver. Get up to date as researchers from Roswell Park Comprehensive Cancer Center …
ILCN article
Inflammation’s Dark Symphony: Lung Cancer and Depression in Concert
… Dr. Barbara Andersen’s research has shown depression severity is associated with …
ILCN article
Gender Disparity in Lung Cancer
… for gender-sensitive approaches in healthcare policy, research, and clinical practice. … Gender Disparity in Lung …
ILCN article
US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective
… of care and limited resources to review applications, researchers say they support the agency’s decision not to …











